SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-001851
Filing Date
2020-01-23
Accepted
2020-01-23 17:21:01
Documents
1
Period of Report
2020-01-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7113
  Complete submission text file 0000899243-20-001851.txt   9337
Mailing Address 285 RIVERSIDE AVE. SUITE 250 WESTPORT CT 06880
Business Address 285 RIVERSIDE AVE. SUITE 250 WESTPORT CT 06880 203-855-0400
CANAAN X L.P. (Reporting) CIK: 0001619859 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38503 | Film No.: 20543056

Mailing Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2
Business Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2 (872) 225-6077
Iterum Therapeutics plc (Issuer) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2765 SAND HILL ROAD MENLO PARK CA 94025
Business Address 2765 SAND HILL ROAD MENLO PARK CA 94025 6508548092
Canaan Partners X LLC (Reporting) CIK: 0001673228 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38503 | Film No.: 20543057